about
Systemic therapy of Cushing's syndromeCushing's diseaseThe Treatment of Cushing's Disease.Everolimus for the treatment of pancreatic neuroendocrine tumors.Up-to 5-year efficacy of pasireotide in a patient with Cushing's disease and pre-existing diabetes: literature review and clinical practice considerations.
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pasireotide for the treatment of Cushing's disease.
@en
Pasireotide for the treatment of Cushing's disease.
@nl
type
label
Pasireotide for the treatment of Cushing's disease.
@en
Pasireotide for the treatment of Cushing's disease.
@nl
prefLabel
Pasireotide for the treatment of Cushing's disease.
@en
Pasireotide for the treatment of Cushing's disease.
@nl
P2860
P1476
Pasireotide for the treatment of Cushing's disease.
@en
P2093
Giorgio Arnaldi
Marco Boscaro
P2860
P304
P356
10.1517/13543784.2010.495943
P407
P577
2010-07-01T00:00:00Z